Results 131 to 140 of about 63,958 (182)

Differences in immune function and cytokine levels among children in different age groups with severe community-acquired pneumonia. [PDF]

Sci Rep
Li L, Li Y, Wang Y, Fu S, Song C.
europepmc   +1 more source

A desirability of outcome ranking for adults with non-severe community-acquired pneumonia: a comparison of physician and patient preferences. [PDF]

Antimicrob Steward Healthc Epidemiol
Finer E, Pulia MS, Harrison JD, Willey J, Carr J, White AT, Edwards SK, Hanson C, Rogers B, Wurst M, Evans P, Carnie MB, Symczak G, Carmichael H, Smith A, Patel PK, Madsen T, Bledsoe J, Howard-Anderson J, Vaughn VM.   +19 more
europepmc   +1 more source

Correction to "Application of Nested Multiplex Polymerase Chain Reaction Respiratory and Pneumonia Panels in Children With Severe Community-Acquired Pneumonia". [PDF]

J Med Virol
europepmc   +1 more source

The impact of the timing of mNGS-guided antibiotic adjustment on clinical outcomes in ICU patients with severe community-acquired pneumonia: a retrospective study. [PDF]

Ann Clin Microbiol Antimicrob
Sun Y, Guo K, Tang J, Zhao J, Zhang X, Yan Y, Yuan L, Zhang Y, Qiu C, Luo J, Chen J, Fang H.   +11 more
europepmc   +1 more source

Comparing routine hematological parameters on COVID-19, bacterial infections, and coinfection in elderly severe community-acquired pneumonia, a retrospective study in primary hospitals. [PDF]

J Family Med Prim Care
Han X, Wang Q, Li D, Zheng Y, Mu J, Wang Y.   +5 more
europepmc   +1 more source

Antibiotic optimization in hospitalized children with non-severe community-acquired pneumonia: lessons from an antimicrobial stewardship intervention (2022-2024). [PDF]

Front Pediatr
Attaianese F, Privato R, Montagnani C, Stivala M, Trapani S, Galli L, Indolfi G.   +6 more
europepmc   +1 more source

Publisher Correction: Effect of hydrocortisone on mortality in patients with severe community-acquired pneumonia. [PDF]

Intensive Care Med
REMAP-CAP Investigators.
europepmc   +1 more source

Traditional Chinese Medicine treatment with syndrome differentiation for patients with severe community-acquired pneumonia: a multicenter, randomized, placebo-controlled trial. [PDF]

J Tradit Chin Med
Jiansheng LI, Haifeng W, Kang Z, Kai X, Suyun LI, Chenxi Z, Yaqing Z.   +6 more
europepmc   +1 more source

Clinical characteristics and risk factors associated with severe community-acquired pneumonia infected by <i>Chlamydia psittaci</i>. [PDF]

Microbiol Spectr
Xu T, Yuan Q, Wang J, Wu Z, Chen Z, Wang Z, Sun W, Zhang M, Ji N, Huang M.   +9 more
europepmc   +1 more source

Comparing the performance of radiomics, nomograms, machine learning, and large language models in predicting 28-day mortality in severe community-acquired pneumonia patients. [PDF]

Front Immunol
Lin T, Wan H, Liang Y, Ming J, Lu J, Guo Z.   +5 more
europepmc   +1 more source